What is the fair value of Innovate Corp (NYSE-VATE) stock?

The current fair value estimate for Innovate Corp (NYSE-VATE) is $9.17. This implies an estimated upside of 12.2% versus the current market price.

Is Innovate Corp (NYSE-VATE) undervalued or overvalued?

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 12.2% versus the current market price.

How is the financial health of Innovate Corp?

The current financial health read for Innovate Corp (NYSE-VATE) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Does Innovate Corp (NYSE-VATE) pay dividends?

The latest available data indicates no current dividend yield for Innovate Corp (NYSE-VATE).

What is the market capitalization of Innovate Corp?

The current market capitalization listed for Innovate Corp is 111.6 M.

What is the enterprise value of Innovate Corp?

The current enterprise value listed for Innovate Corp is 729.3 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Innovate Corp?

The ticker symbol for Innovate Corp is NYSE-VATE, and the stock is listed on NYSE.

Where is Innovate Corp (NYSE-VATE) listed?

Innovate Corp (NYSE-VATE) is listed on NYSE.

What is the debt-to-total-capital ratio for Innovate Corp?

The current debt-to-total-capital ratio listed for Innovate Corp is 83.5%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Innovate Corp?

The free float listed for Innovate Corp is 30.5%. Free float helps investors understand how much of the share base is available for public trading.

Innovate Corp (VATE) Fair Value & Stock Analysis

Innovate Corp (VATE)

INNOVATE Corp. is a New York-based company with common stock listed on the NYSE under the ticker VATE. Through its subsidiaries, the company operates in three segments: Infrastructure, Life Sciences, and Spectrum. Its Infrastructure activities include industrial construction, structural steel fabrication and erection, heavy steel plate work, facility maintenance, digital engineering, 3-D modeling and detailing, and the manufacture of customized products used in construction and industrial applications. The Life Sciences segment develops products aimed at early knee osteoarthritis and offers aesthetic and medical skin technologies. The Spectrum segment operates over-the-air broadcasting stations across the United States. Formerly known as HC2 Holdings, Inc., the company adopted the INNOVATE Corp. name in September 2021 and was incorporated in 1994.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Overall Financial Health	Dividend Yield	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
NYSE-VATE	$9.17	12.2% Upside	Fair	Not available	Not available	Good	0.0%	0.1x	111.6 M	729.3 M	83.5%	30.5%	0.3	-8.0%	-439.6%